The Patent Finder

Amyl Therapeutics SRL

Also on record
Records under this name other than the patents Amyl Therapeutics SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Showing 1 to 2 of 2 · Back to Amyl Therapeutics SRL

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,692,017General amyloid interaction motif (GAIM)
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,988,444Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity
Lapsed on the fee record
Ended Jun 5, 2026 · USPTO record
Lapsed on the fee recordEnded Jun 5, 2026USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited